Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors

R. M. Jordan, John Kendall, J. L. Seaich, J. P. Allen, C. A. Paulsen, C. W. Kerber, W. P. Vanderlaan

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Cerebrospinal fluid (CSF) concentrations of corticotropin, growth hormone, thyrotropin, prolactin, luteinizing hormone, and follicle stimulating hormone were measured in 28 patients with various neurologic disorders, in 49 patients with pituitary tumors of whom 22 had suprasellar extension, and in 6 patients with craniopharyngiomas. With the exception of 1 patient with pseudotumor cerebri, CSF adenohypophyseal hormone concentrations were low in patients with neurologic disease and in patients with pituitary tumor without suprasellar extension. In marked contrast, 21 of 22 patients with suprasellar extension of a pituitary tumor and 2 of 6 patients with a craniopharyngioma had elevations of one or more CSF adenohypophyseal hormones. Posttreatment CSF adenohypophyseal hormone levels fell from previously elevated levels in 4 of 5 patients. These data suggest that an elevated CSF adenohypophyseal hormone concentration is a sensitive indicator of suprasellar extension of a pituitary tumor, and posttreatment measurements are useful in determining efficacy of therapy.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalAnnals of Internal Medicine
Volume85
Issue number1
StatePublished - 1976
Externally publishedYes

Fingerprint

Pituitary Neoplasms
Cerebrospinal Fluid
Hormones
Anterior Pituitary Hormones
Craniopharyngioma
Nervous System Diseases
Pseudotumor Cerebri
Follicle Stimulating Hormone
Thyrotropin
Luteinizing Hormone
Prolactin
Adrenocorticotropic Hormone
Growth Hormone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jordan, R. M., Kendall, J., Seaich, J. L., Allen, J. P., Paulsen, C. A., Kerber, C. W., & Vanderlaan, W. P. (1976). Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors. Annals of Internal Medicine, 85(1), 49-55.

Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors. / Jordan, R. M.; Kendall, John; Seaich, J. L.; Allen, J. P.; Paulsen, C. A.; Kerber, C. W.; Vanderlaan, W. P.

In: Annals of Internal Medicine, Vol. 85, No. 1, 1976, p. 49-55.

Research output: Contribution to journalArticle

Jordan, RM, Kendall, J, Seaich, JL, Allen, JP, Paulsen, CA, Kerber, CW & Vanderlaan, WP 1976, 'Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors', Annals of Internal Medicine, vol. 85, no. 1, pp. 49-55.
Jordan RM, Kendall J, Seaich JL, Allen JP, Paulsen CA, Kerber CW et al. Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors. Annals of Internal Medicine. 1976;85(1):49-55.
Jordan, R. M. ; Kendall, John ; Seaich, J. L. ; Allen, J. P. ; Paulsen, C. A. ; Kerber, C. W. ; Vanderlaan, W. P. / Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors. In: Annals of Internal Medicine. 1976 ; Vol. 85, No. 1. pp. 49-55.
@article{08d91272e5234ae0beafda83bf12289e,
title = "Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors",
abstract = "Cerebrospinal fluid (CSF) concentrations of corticotropin, growth hormone, thyrotropin, prolactin, luteinizing hormone, and follicle stimulating hormone were measured in 28 patients with various neurologic disorders, in 49 patients with pituitary tumors of whom 22 had suprasellar extension, and in 6 patients with craniopharyngiomas. With the exception of 1 patient with pseudotumor cerebri, CSF adenohypophyseal hormone concentrations were low in patients with neurologic disease and in patients with pituitary tumor without suprasellar extension. In marked contrast, 21 of 22 patients with suprasellar extension of a pituitary tumor and 2 of 6 patients with a craniopharyngioma had elevations of one or more CSF adenohypophyseal hormones. Posttreatment CSF adenohypophyseal hormone levels fell from previously elevated levels in 4 of 5 patients. These data suggest that an elevated CSF adenohypophyseal hormone concentration is a sensitive indicator of suprasellar extension of a pituitary tumor, and posttreatment measurements are useful in determining efficacy of therapy.",
author = "Jordan, {R. M.} and John Kendall and Seaich, {J. L.} and Allen, {J. P.} and Paulsen, {C. A.} and Kerber, {C. W.} and Vanderlaan, {W. P.}",
year = "1976",
language = "English (US)",
volume = "85",
pages = "49--55",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "1",

}

TY - JOUR

T1 - Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors

AU - Jordan, R. M.

AU - Kendall, John

AU - Seaich, J. L.

AU - Allen, J. P.

AU - Paulsen, C. A.

AU - Kerber, C. W.

AU - Vanderlaan, W. P.

PY - 1976

Y1 - 1976

N2 - Cerebrospinal fluid (CSF) concentrations of corticotropin, growth hormone, thyrotropin, prolactin, luteinizing hormone, and follicle stimulating hormone were measured in 28 patients with various neurologic disorders, in 49 patients with pituitary tumors of whom 22 had suprasellar extension, and in 6 patients with craniopharyngiomas. With the exception of 1 patient with pseudotumor cerebri, CSF adenohypophyseal hormone concentrations were low in patients with neurologic disease and in patients with pituitary tumor without suprasellar extension. In marked contrast, 21 of 22 patients with suprasellar extension of a pituitary tumor and 2 of 6 patients with a craniopharyngioma had elevations of one or more CSF adenohypophyseal hormones. Posttreatment CSF adenohypophyseal hormone levels fell from previously elevated levels in 4 of 5 patients. These data suggest that an elevated CSF adenohypophyseal hormone concentration is a sensitive indicator of suprasellar extension of a pituitary tumor, and posttreatment measurements are useful in determining efficacy of therapy.

AB - Cerebrospinal fluid (CSF) concentrations of corticotropin, growth hormone, thyrotropin, prolactin, luteinizing hormone, and follicle stimulating hormone were measured in 28 patients with various neurologic disorders, in 49 patients with pituitary tumors of whom 22 had suprasellar extension, and in 6 patients with craniopharyngiomas. With the exception of 1 patient with pseudotumor cerebri, CSF adenohypophyseal hormone concentrations were low in patients with neurologic disease and in patients with pituitary tumor without suprasellar extension. In marked contrast, 21 of 22 patients with suprasellar extension of a pituitary tumor and 2 of 6 patients with a craniopharyngioma had elevations of one or more CSF adenohypophyseal hormones. Posttreatment CSF adenohypophyseal hormone levels fell from previously elevated levels in 4 of 5 patients. These data suggest that an elevated CSF adenohypophyseal hormone concentration is a sensitive indicator of suprasellar extension of a pituitary tumor, and posttreatment measurements are useful in determining efficacy of therapy.

UR - http://www.scopus.com/inward/record.url?scp=0017153389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017153389&partnerID=8YFLogxK

M3 - Article

C2 - 180861

AN - SCOPUS:0017153389

VL - 85

SP - 49

EP - 55

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 1

ER -